Outset Medical (Nasdaq: OM) announced today that the FDA says it addressed all issues cited in a 2023 warning letter.
We are pleased to achieve this important milestone and remain vigilant as we work to continuously improve everything we do on behalf of the patients and providers we serve.” About Outset Medical, Inc.
Inc. (NASDAQ:OM), a medical technology company focused on innovating dialysis treatment, has resolved all concerns raised in a Warning Letter from the U.S. Food and Drug Administration (FDA) dating ...
Inc., a company specializing in electromedical and electrotherapeutic apparatus with a market capitalization of $44 million, announced on Thursday a significant amendment to its corporate bylaws ...
Outset Medical, Inc. (OM) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of ...
Outset Medical has announced a $169 million private placement financing and a new debt facility of up to $125 million, aiming to retire prior debt and bolster its financial position. This ...
Outset Medical, Inc. SAN JOSE, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to ...
Outset Medical, Inc. (OM) stock price is 0.85 and Outset Medical, Inc. (OM) 10-day simple moving average is 0.81. Outset Medical, Inc. (OM) stock price is 0.85 and Outset Medical, Inc. (OM ...
Outset Medical (OM) announced it has been notified by the FDA that all issues cited in a warning letter the company received in July of 2023 ...